NCT07436806 SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery
| NCT ID | NCT07436806 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Chronic Post-thoracotomy Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-03-01 with a primary completion date of 2026-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the efficacy of ultrasound-guided Serratus Posterior Superior (SPS) block compared to surgeon-administered intercostal blockade in preventing chronic pain at 3, 6, and 12 months following Video-Assisted Thoracoscopic Surgery (VATS).
Eligibility Criteria
Inclusion Criteria: * ASA physical status I-III. * Scheduled for elective unilateral Video-Assisted Thoracoscopic Surgery (VATS). Exclusion Criteria: * History of allergy to local anesthetics. * Pre-existing chronic pain syndrome or neuropathic pain. * Psychiatric disorders affecting pain assessment. * Coagulation disorders. * Previous thoracic surgery on the same side.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07436806 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Chronic Post-thoracotomy Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07436806 currently recruiting?
Yes, NCT07436806 is actively recruiting participants. Contact the research team at bciftci@medipol.edu.tr for enrollment information.
Where is the NCT07436806 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07436806 clinical trial?
NCT07436806 is sponsored by Medipol University. The trial plans to enroll 40 participants.